Page last updated: 2024-10-31

nafamostat and Hypothermia

nafamostat has been researched along with Hypothermia in 1 studies

nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic

Hypothermia: Lower than normal body temperature, especially in warm-blooded animals.

Research Excerpts

ExcerptRelevanceReference
"Nafamostat is a synthetic protease inhibitor with anticoagulant effects."5.35Nafamostat prevents hypothermia and improves survival time after administration of lipopolysaccharide in a mouse surgical model. ( Adachi, YU; Doi, M; Itagaki, T; Katoh, H; Obata, Y; Sato, S; Suzuki, K, 2009)
"Nafamostat is a synthetic protease inhibitor with anticoagulant effects."1.35Nafamostat prevents hypothermia and improves survival time after administration of lipopolysaccharide in a mouse surgical model. ( Adachi, YU; Doi, M; Itagaki, T; Katoh, H; Obata, Y; Sato, S; Suzuki, K, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adachi, YU1
Obata, Y1
Suzuki, K1
Katoh, H1
Itagaki, T1
Doi, M1
Sato, S1

Other Studies

1 other study available for nafamostat and Hypothermia

ArticleYear
Nafamostat prevents hypothermia and improves survival time after administration of lipopolysaccharide in a mouse surgical model.
    Journal of anesthesia, 2009, Volume: 23, Issue:4

    Topics: Analysis of Variance; Anesthesia; Anesthetics, Inhalation; Animals; Benzamidines; Body Temperature;

2009